期刊文献+

血清降钙素原及C反应蛋白在感染性疾病中的应用前景 被引量:9

Application potential of serum procalcitonin and C-reactive protein in infectious diseases
下载PDF
导出
摘要 血清降钙素原(PCT)是降钙素前肽物质,正常情况下由甲状腺C细胞产生。C反应蛋白(CRP)是一种急性时相反应蛋白,在白细胞介素-6作用下由肝细胞分泌产生。有关资料表明,感染时血清PCT及CRP水平升高,并与感染严重程度呈正相关。在临床检测中发现两者在诊断感染性疾病灵敏度上差异不明显,但在特异性上PCT明显高于CRP。两者联合检测在鉴别诊断感染性疾病和非感染性疾病、监测危重症及感染、指导抗生素的合理应用、判断治疗效果及评估预后上有重要的临床应用价值与良好的应用前景。PCT产生机制及其在重症感染时的来源、作用机制尚不清楚,有待于进一步研究。 Serum procalcitonin (PCT) is propeptide of calcitonin, normally produced by thyroid C cells. And C-reactive protein (CRP) is a sort of acute phase protein secreted by hepatic cells in the induction of IL-6. Substantial studies have shown that the serum levels of PCT and CRP are increased remarkably in the patients who suffered from infectious diseases, and the levels are positively correlated with the severity of the infectious disorders. There is no apparent difference in the sensitivity of diagnosing infectious diseases between the 2 proteins, but the specificity of PCT is higher than that of CRP. It is of great clinical application value and promising application prospect when the 2 proteins are combined together in the differential diagnosis of infection and noninfectious diseases, the monitoring of critical illness and severe infection, the guiding of appropriate antibiotics usage, and the evaluation of curative effects and prognosis. However, how the PCT is produced and through what mechanism it exerts effect remain unclear and need further studies.
机构地区 解放军第
出处 《中华老年多器官疾病杂志》 2013年第9期693-696,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 降钙素原 C反应蛋白质 传染病 procalcitonin C-reactive protein communicable diseases
  • 相关文献

参考文献14

二级参考文献53

  • 1王佩燕.鲜明循证医学特色的治疗指南——严重脓毒症和感染性休克治疗指南评介[J].中国急救医学,2005,25(3):217-218. 被引量:6
  • 2邱菁华,刘励军,Philippe Sauder.血清降钙素原和感染可能性评分对危重症患者感染预测的比较研究[J].中国急救医学,2005,25(6):391-394. 被引量:18
  • 3胡如雪.降钙素原(PCT)的临床应用价值[J].江西医学检验,2005,23(3):259-259. 被引量:39
  • 4Okajima K.Multiple organ failure associated with severe infection-the molecular mechanism (s) and new therapeutic strategies.Nippon Rinsho,2007,65 Suppl 3:S619-626.
  • 5Giannoudis PV,Hildebiand E,Pape HC.Inflammatory serum markers in patients with multiple trauma:can they predict outcome.J Bone Joint Surg,2004,86(3):313-323.
  • 6Buckley TA,Gomersall CD,Ramsay SJ.Validation of the multiple organ dysfunctions (MOD) score in critically ill medical and surgical patients.Intensive Care Med,2003,29(12):2216-2222.
  • 7Mannan MA,Shahidullah M,Noor MK,et al.Utility of C-reactive protein and hematological parameters in the detection of neonatal sepsis.Mymensingh Med J,2010,19(2):259-263.
  • 8Shimada Y,Komatsu Y,Ikezawa-Suzuki I,et al.The effect of periodontal treatment on serum leptin,interleukin-6,and Creactive protein.J Periodontol,2010,3(2):424-427.
  • 9Hensler T,Sanerland S,Lefering R.The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma.Shock,2003,20(8):420-426.
  • 10Atao(g)lu HE,Yilmaz F,Uzunhasan I,et al.Procalcitonin:a novel cardiac marker with prognostic value in acute coronary syndrome.J Int Med Res,2010,38(1):52-61.

共引文献246

同被引文献89

  • 1马军花,王绪荣.剖宫产术中应用碘伏联合甲硝唑预防感染120例[J].中国实用医刊,2010,37(11):64-65. 被引量:4
  • 2国家药典委员会.中华人民共和国药典临床用药须知[M].北京:人民卫生出版社,2005:835.
  • 3葛均波,徐永健.内科学[M].第8版.北京:人民卫生出版社,2013.259~265.
  • 4Adam I, Adam E S, Gerais A S.Randomized trial of ceftriaxone prophylaxis in elective cesarean section[J].Saudi Med J, 2005,26 ( 3 ): 500-501.
  • 5Ruiz-Alvarez M J, Garc i a-Valdecasas S, De Pablo R, et al.Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis[J].Intens Care Med, 2009, 24 ( 1 ) : 63-71.
  • 6孔浩,丁震,朱先超,高晓阳,孙圣斌,吴杰,赵刚,王春友,侯晓华.急性胰腺炎患者血浆D-二聚体变化与病情相关性研究[J].中华内科杂志,2007,46(12):1011-1013. 被引量:13
  • 7CHRIST-CRAIN M, STOLZ D, BINGISSER R, et al. Procal- citonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial[J]. Am J Respir Crit Care Med, 2006,174(1) :84-93.
  • 8Cuquemelle E,Soulis F,Villers D,et al.Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia?A multicentre study[J].Intensive Care Med,2011,37(5):796-800.
  • 9Lanoix JP,Bourgeois AM,Schmidt J,et al.Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus[J].Lupus,2011,20(2):125-130.
  • 10Miedema KG,de Bont ES,Elferink RF,et al.The diagnostic value of CRP,IL-8,PCT,and sTREM-1in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia[J].Support Care Cancer,2011,19(10):1593-1600.

引证文献9

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部